Literature DB >> 12046873

Laser in situ keratomileusis with the Nidek EC-5000 excimer laser for astigmatism greater than 4.00 D.

Marcelo Mastromonico Lui1, Marcia Ap Grandini Silas, Benny Apelbaum, Akioshi Oshima.   

Abstract

PURPOSE: To evaluate laser in situ keratomileusis (LASIK) performed with the Nidek EC-5000 excimer laser in 66 astigmatic eyes with cylinder from 4.00 to 8.00 D.
METHODS: LASIK was performed with the Nidek EC-5000 excimer laser in 66 astigmatic eyes with cylinder from 4.00 to 8.00 D. Based on Chayet's nomogram, ablation zone diameters were 5.5 mm (steep meridian ablation) to 7.5 mm (flat meridian ablation). In eyes with simple myopic astigmatism, mixed astigmatism, and compound myopic astigmatism (low sphere), ablation was performed in both meridians. In eyes with simple hyperopic astigmatism, ablation was performed in the flat meridian alone. In eyes with compound hyperopic astigmatism, ablation zone diameter was 5.5 mm and the transition zone was 7.5 mm.
RESULTS: Uncorrected visual acuity was 20/40 or better in 89% of eyes and was equal to preoperative best spectacle-corrected visual acuity in 62% of eyes. No eyes lost lines of best spectacle-corrected visual acuity.
CONCLUSIONS: Using the Nidek EC-5000 excimer laser, we had satisfactory results in the treatment of astigmatic eyes with cylinder from 4.00 to 8.00 D, based on Chayet's nomogram.

Entities:  

Mesh:

Year:  2002        PMID: 12046873     DOI: 10.3928/1081-597X-20020502-06

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  2 in total

1.  Ocular residual astigmatism's effect on high myopic astigmatism LASIK surgery.

Authors:  M A Teus; C Arruabarrena; J L Hernández-Verdejo; R Cañones; D G Mikropoulos
Journal:  Eye (Lond)       Date:  2014-06-27       Impact factor: 3.775

2.  Femtosecond laser-assisted sub-Bowman keratomileusis versus laser-assisted subepithelial keratomileusis to correct myopic astigmatism.

Authors:  Juan Gros-Otero; Montserrat Garcia-Gonzalez; Miguel A Teus; MariLuz Iglesias-Iglesias; Carlos Gimenez-Vallejo
Journal:  J Optom       Date:  2016-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.